Rash Due to Lung Cancer Drug May Be Linked to Better Survival, Hospital Grosshansdorf Study
MONDAY, Dec. 20 (HealthDay News) -- Lung cancer patients who develop a rash after treatment with the drug cetuximab (Erbitux) have better outcomes, according to a new study.